161 related articles for article (PubMed ID: 11363129)
1. Combining d4T/ddI looks promising.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
[TBL] [Abstract][Full Text] [Related]
2. New questions about an old combination--ddI + d4T.
Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
[TBL] [Abstract][Full Text] [Related]
3. ddI plus d4T.
James JS
AIDS Treat News; 1996 Sep; (No 254):4. PubMed ID: 11363818
[TBL] [Abstract][Full Text] [Related]
4. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
5. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team.
Mobley JE; Pollard RB; Schrader S; Adler MH; Kelleher T; McLaren C
AIDS; 1999 Jul; 13(11):F87-93. PubMed ID: 10449279
[TBL] [Abstract][Full Text] [Related]
6. d4T plus ddI: warning for pregnant women.
AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
[TBL] [Abstract][Full Text] [Related]
7. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Dragovic G; Jevtovic D
Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir drug interactions: ddI and d4T.
TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
[No Abstract] [Full Text] [Related]
9. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
[TBL] [Abstract][Full Text] [Related]
11. Three-drug combos.
Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
[TBL] [Abstract][Full Text] [Related]
12. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
13. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
[TBL] [Abstract][Full Text] [Related]
14. Some competition for 1592.
GMHC Treat Issues; 1997; 11(4/5):10-1. PubMed ID: 11364373
[TBL] [Abstract][Full Text] [Related]
15. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
Zala C; Salomón H; Cahn P
Antivir Ther; 1999; 4 Suppl 3():95-9. PubMed ID: 16021880
[TBL] [Abstract][Full Text] [Related]
17. Back to the nukes.
Smart T
GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
[TBL] [Abstract][Full Text] [Related]
18. Top AIDS researchers' strategy for antiretroviral treatment.
AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
[TBL] [Abstract][Full Text] [Related]
19. d4T plus ddI antiviral results.
AIDS Treat News; 1996 Feb; (no 241):3. PubMed ID: 11363187
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyrea and ddI: French study published.
James JS
AIDS Treat News; 1995 Sep; (no 230):6. PubMed ID: 11362759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
